Elevated risk for invasive meningococcal disease among persons with HIV.
about
Meningococcal VaccinationsHistory of Meningococcal Outbreaks in the United States: Implications for Vaccination and Disease Prevention.Vaccination in HIV-infected adults.Improvements in HIV care engagement and viral load suppression following enrollment in a comprehensive HIV care coordination programImmunogenicity and safety of meningococcal C conjugate vaccine in children and adolescents infected and uninfected with HIV in Rio de Janeiro, Brazil.Risk of invasive meningococcal disease in children and adults with HIV in England: a population-based cohort study.Risk Factors for Serogroup C Meningococcal Disease during Outbreak among Men who Have Sex with Men, New York City, New York, USA.Effect of HIV Housing Services on Engagement in Care and Treatment, New York City, 2011.Association of CMV, HBV, or HCV co-infection with vaccine response in adults with well-controlled HIV infectionMeningococcal Disease in Patients With Human Immunodeficiency Virus Infection: A Review of Cases Reported Through Active Surveillance in the United States, 2000-2008.Vaccinations for the HIV-Infected Adult: A Review of the Current Recommendations, Part I.An unwanted guest: Neisseria meningitidis - carriage, risk for invasive disease and the impact of vaccination with insight on Italy incidence.Neisseria meningitidis serogroup C sepsis and septic arthritis in an HIV-positive man.Risk factors for community-acquired bacterial meningitis.Increased Risk for Meningococcal Disease among Men who have Sex with Men in the United States, 2012-2015.Background Paper for the update of meningococcal vaccination recommendations in Germany: use of the serogroup B vaccine in persons at increased risk for meningococcal disease.British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015.Immunization of HIV-infected adult patients - French recommendations.Progress toward the global control of Neisseria meningitidis: 21st century vaccines, current guidelines, and challenges for future vaccine development.
P2860
Q26752993-A73099C3-7C72-4B77-B24D-4FD5D55F381CQ30249427-C522A586-668E-42BE-B0E5-B3929654B4E4Q33980764-F4E7ED09-E2EB-4F10-A67B-C228449EABB6Q34974485-31E410E9-02A5-4FCF-A9A6-044DDFD80400Q35680467-5A4AED13-86AA-41F0-87A3-C38921145371Q35865540-6278296D-3492-4623-879D-388BC3DFE81DQ35897065-F2E3BD7D-2900-4F50-9486-35B85494971DQ36137776-D1D45D87-8735-4B3F-A4A2-743DC4A32983Q37131078-12684D0A-A7A6-4D82-97A0-FBB1A8F20800Q37517988-6C32354F-AE87-45E0-B8F7-6F3C02294A11Q38639401-FA7C70EA-0749-4039-9BFD-5804F3BF3DB3Q38775024-47C51892-6B73-4A0E-8F7F-197DF84057EBQ39009802-AFD213A8-9FA1-4C6A-B245-386BA9AD032AQ39182388-3709E9C9-7F65-4070-8949-F005339D3495Q40201120-71E1332B-D15E-45E9-8F3E-4AECD8933509Q40408137-0D1E3128-6E92-4198-B600-14C2FED1D5B8Q40560650-91B417F8-32EB-493D-8ADA-D8AFD545B643Q40615516-1EF97FE1-92B6-41B5-B614-8D455F479650Q54255446-72AE171C-FB64-4B3F-A828-925B1894DAF1
P2860
Elevated risk for invasive meningococcal disease among persons with HIV.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Elevated risk for invasive meningococcal disease among persons with HIV.
@en
Elevated risk for invasive meningococcal disease among persons with HIV.
@nl
type
label
Elevated risk for invasive meningococcal disease among persons with HIV.
@en
Elevated risk for invasive meningococcal disease among persons with HIV.
@nl
prefLabel
Elevated risk for invasive meningococcal disease among persons with HIV.
@en
Elevated risk for invasive meningococcal disease among persons with HIV.
@nl
P2093
P1476
Elevated risk for invasive meningococcal disease among persons with HIV.
@en
P2093
Arianne Ramautar
Colin Shepard
Joseph Kennedy
Laura Miller
Linda Steiner-Sichel
Lola Arakaki
Sara Bodach
Sarah L Braunstein
Stephanie Ngai
P356
10.7326/0003-4819-160-1-201401070-00731
P407
P577
2014-01-01T00:00:00Z